Skip to main content

Select Drug Profiles

Conference Correspondent
Adding Abatacept to the Euro-Lupus Nepthritis Regimen in Patients with Lupus Nephritis: Results from ACCESS, a 24-Week, Double-Blind Controlled Trial
Read More
Conference Correspondent
Association of Psoriasis and Psoriatic Arthritis with Lupus
Read More
Perspectives
“Pharma Value”
David B. Nash, MD, MBA
Read More
Perspectives
Fall Follies: The ACA Lurches into Operation
Joseph R. Antos, PhD
Read More
Practice Management
Development of a Medicare Beneficiary Comprehension Test: Assessing Medicare Part D Beneficiaries’ Comprehension of Their Benefits
Meghana Aruru, PhD, MBA, BSPharm, J. Warren Salmon, PhD
Stakeholder Perspective
Understanding the Options: An Essential Ingredient in Our Evolving Healthcare System
by Joseph R. Antos, PhD
Read More
Practice Management
The Economics of Biosimilars
Erwin A. Blackstone, PhD, Joseph P. Fuhr, Jr, PhD
Stakeholder Perspective
Modeling the Future Economic Impact of Biosimilars’ Entry into the US Market
by Grant D. Lawless, RPh, MD, FACP
Read More
Practice Management
The Incidence Rate and Economic Burden of Community-Acquired Pneumonia in a Working-Age Population
Jonah Broulette, ASA, MAAA, Holly Yu, MSPH, Kosuke Iwasaki, FIAJ, MAAA, Reiko Sato, PhD, Bruce S. Pyenson, FSA, MAAA
Stakeholder Perspective
CAP Is a Burden for All Ages—Prevention Strategies Are Key
by F. Randy Vogenberg, PhD, FASHP
Read More
Practice Management
Technological Changes Can Transform Medicine by 2020: A Conversation with the Futurist Jim Carroll
Rosemary Frei, MSc
Read More
Diagnosis and Management of Myelofibrosis: Practical Strategies for the Healthcare Team Proceedings from a Multidisciplinary Roundtable
Jason R. Gotlib, MD, MS
Read More
Intensive Treatment Early in Type 1 Diabetes Produces Substantial Long-Term Benefits
Mary Mosley
Read More
Page 164 of 244
Results 1631 - 1640 of 2434